Not suitable for individuals with fish, shellfish, or other known allergies (adjust depending on your ingredient source)
Simultaneously, Novo Nordisks SELECT trial confirmed a 20% reduction in major adverse cardiac events with semaglutide, expanding prescriber confidence and unlocking reimbursement across high-risk populations
CERTIFICATE OF ANALYSIS Product NameGlycine Propionyl L-Carnitine HCl Test ItemsSpecificationResults AppearanceWhite or off-White powderConformsvisual State of solution98%98.6%visual Specific Rotation-19.51-19.7CP2010 Assay(Dry basis)98%98.6%TITRATION Assay(Glycine)22.023.5%22.7%TITRATION Chloride CI14.6% Heavy metals (Pb)0.0002%0.0001%CP2010 Arsenic (AS2O2)0.0001%0.0001%CP2010 Iron (Fe)0.0002%0.0001%CP2010 Loss on drying0.5%0.31%CP2010 Residue on ignition0.10%0.05%CP2010 Microbial Tests Total Bacteria Count1000500CP2010 Escherichia coli10030CP2010 SalmonellaNegative Negative CP2010 SalmonellaNegative Negative CP2010 ConclusionThe product meets the requirements of factory
We believe that dosing specifically for this type of a treatment to mitigate side effects is very much right down the center of what that compounding exemption is built for. A recent bullish note from Morgan Stanley argued that Hims is well positioned to transition the compounding process from 503B to 503A pharmacies, claiming that 503A pharmacies are regulated at the state level, rather than by the FDA
Aesthetic applications: Post-laser healing Post-microneedling recovery Reducing inflammation after threads or PRP This powerful healing injectable peptide enhances fibroblast migration and angiogenesis, which are foundational for tissue restoration
For more information on semaglutide, we recommend reading through the FDAs full prescribing information document here
